Crucell to acquire assets of Xcellerex - MarketLine Financial Deals

Crucell to acquire assets of Xcellerex

Crucell to acquire assets of Xcellerex - MarketLine Financial Deals
Crucell to acquire assets of Xcellerex
Published Jun 17, 2009
2 pages — Published Jun 17, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Crucell, NV, a Netherlands-based biopharmaceutical company, has agreed to acquire the assets of Xcellerex, Inc., a US-based developer and manufacturer of biomolecules.

  
Source:
Document ID
MA05577_090623
Country
Country
Ticker
CRXL=NL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Crucell to acquire assets of Xcellerex" Jun 17, 2009. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Crucell-to-acquire-assets-of-Xcellerex-2052-5308>
  
APA:
MarketLine Financial Deals. (2009). Crucell to acquire assets of Xcellerex Jun 17, 2009. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Crucell-to-acquire-assets-of-Xcellerex-2052-5308>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.